Laglidadg homing endonuclease variants having mutations in two functional subdomains and use thereof.

Details for Australian Patent Application No. 2006314220 (hide)

Owner Cellectis

Inventors Paques, Frederic

Agent Fisher Adams Kelly

Pub. Number AU-A-2006314220

PCT Pub. Number WO2007/057781

Priority PCT/ IB2005/003568 25.10.05 IB

Filing date 25 October 2006

Wipo publication date 24 May 2007

International Classifications

C12N 9/22 (2006.01) Enzymes, e.g. ligases (6.) - Ribonucleases

C12N 15/10 (2006.01) Mutation or genetic engineering - Processes for the isolation, preparation or purification of DNA or RNA

C12N 15/55 (2006.01) Mutation or genetic engineering - Hydrolases (3)

C12N 15/64 (2006.01) Mutation or genetic engineering - General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host

C12N 15/79 (2006.01) Mutation or genetic engineering - Vectors or expression systems specially adapted for eukaryotic hosts

C12N 15/82 (2006.01) Mutation or genetic engineering - for plant cells

Event Publications

8 May 2008 PCT application entered the National Phase

  PCT publication WO2007/057781 Priority application(s): WO2007/057781

4 October 2012 Corrigenda

  PCT applications that have entered the National Phase - Name Index Under the name Cellectis, Application No. 2006314220, under INID (22) correct the date to 03.10.2006

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006314226-Therapeutic uses of steroidal compounds

2006314218-Tape printing apparatus